News and Opinions
Time’s Arrow – Brief exposure to rapamycin has the same anti-ageing effects as lifelong treatment
Just published! Some are hailing this promising discovery the next Fountain of Youth, but let's not get carried away. Brief exposure to drug #rapamycin has the same anti-aging effects as lifelong treatment. The #MaxPlanckInstitute made headlines in the #longevity and...
Pioneering stem-cell trials in Japan report promising early results
Has public enthusiasm for #IPSCs waned in Japan? The subject article addresses the topic by focusing on three ongoing studies. Transplanting reprogrammed heart muscle stem cells into a patient. Transplanting IPSC derived #cornea cells- with some vision improvement...
Mystery cells that create blood stem cells in mammals identified
by University of New South Wales - Phys.org Imagine if one day blood transfusions from strangers were not needed because they could be produced from cells that line your own blood vessels' cells. While that day is still some years off, medical researchers at UNSW...
Regenerative medicine is now ready to drive longevity forward
Regenerative Medicine Foundation director highlights the need for patient advocacy in longevity and calls for treatments to be made available to all – not just the few. Author: Danny Sullivan - Link to Article Regenerative medicine is one of the most promising areas...
New web portal gives scientists access to dozens of neurodegenerative disease stem cells
Image Caption: Courtesy of the Conklin lab, Gladstone Institutes, San Francisco, CA With just a few clicks of a mouse and taps on a keyboard, researchers around the world can now order stem cells that National Institutes of Health (NIH) Center for Alzheimer’s and...
Defying death: Japan and Singapore lead Asia’s stem cell research race
A continental race within a global race? Here's the byline- "In the world's fastest-aging societies, regenerative therapies attract the rich and curious." There's way too much info to unpack from from this lengthy article from #NikkeiAsia. Bottom line is that...
This startup wants to copy you into an embryo for organ harvesting
By Antonio Regalado - MIT Technology Review With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics. The company, Renewal Bio, is pursuing recent advances in stem-cell technology and artificial...
Artificial Intelligence Enters Stem Cell Research
Written by: Foley & Lardner LLP - JDSupra.com A major step forward in using Artificial Intelligence (AI) for scientific discovery in the field of stem cell research was recently reported1, reflecting the continued growth of the technology and stressing the need...
Scientists Partially Revived Pig Organs An Hour After Death In ‘Stunning’ New Research
Here's a headline you don't see every day. Stunning- #organs revived after death! Could this one day be an answer to organ shortages? Or a plot straight out of a dystopian TV show on the SyFy Channel. Article in #Forbes provides the quick takeaway: "The research works...
Ageing and rejuvenation of tissue stem cells and their niches
Abstract Most adult organs contain regenerative stem cells, often organized in specific niches. Stem cell function is critical for tissue homeostasis and repair upon injury, and it is dependent on interactions with the niche. During ageing, stem cells decline in their...
An abundance of CAR-Ts: $37B cell therapy cancer market can’t support ‘congested’ pipeline, report says
Image caption: Market over-saturation is especially pronounced in acute lymphocytic leukemia, which has more than 300 drugs in the pipeline, plus two that boast FDA approvals, GlobalData points out. (Mohammed Haneefa Nizamudeen/iStock/Getty Images Plus) By Fraiser...
Pediatric Urologist Dr. Anthony Atala to Receive 2022 Jacobson Innovation Award
Dr. Atala leads an interdisciplinary team that has developed 15 clinically used tissue applications and is working on more than 40 tissues and organs Newswise — CHICAGO (June 10, 2022): Anthony Atala, MD, FACS, Winston-Salem, North Carolina, will be presented with the...
New stem cell models for aging and eye diseases
Seeing a brighter future! Highly interesting article. Using stem modeling with #IPSCs, researchers at the #UniversityofMelbourne developed genetic roadmaps for two causes of irreversible #blindness - Primary Open-Angle Glaucoma #POAG and age-related macular...
A Blueprint for Turning Stem Cells Into Sensory Interneurons
image Caption: Sensory interneurons (with nuclei in red) derived from mouse stem cells. Credit: UCLA Broad Stem Cell Research Center Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed a...
Reactivating Type 1 diabetics’ pancreatic stem cells to produce insulin
image caption: Microscope image of pancreatic tissue, magnification 25X. Shows Islets of Langerhans (lightly stained, pink areas - composed of alpha and beta cells, endocrine tissue), and exocrine tissue (darker, surrounding tissue, secretes digestive enzymes)....
Stem Cells Used to Repair Heart Defects in Children
Doctors turn to stem cell treatment to heal the youngest hearts Almost one out of 100 babies are born with a heart defect each year in the United States. Many of these babies will need surgery within weeks of birth, followed by more surgeries throughout their lives....
The chemical controlling life and death in hair follicles
Image Caption: New research into factors that control the life and death of hair follicle cells could help people with baldness, as well as wound healing. Credit: Helpaeatcontu/Wikimedia by Jules Bernstein, University of California - Riverside A single chemical is key...
Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buy
By Fraiser Kansteiner - Fierce Pharma Just a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories agreed to throw down $875 million cash...
Vertex absorbs ViaCyte and its stem cell-based diabetes treatment for $320M, clearing out competition
By Max Bayer - Fierce Biotech Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday throws...
A major step forward for organ biofabrication
By recreating the helical structure of heart muscles, researchers improve understanding of how the heart beats By Leah Burrows - Harvard John A Paulson School of Engineering and Applied Sciences Heart disease — the leading cause of death in the U.S. — is so deadly in...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.


















